RxDataScience ’s Post

The needs, practices, and perceptions of outsourcers at small and emerging sponsor organizations are not necessarily the same compared to the wider audience of Phase II/III clinical development outsourcers. It's important to keep a pulse on this subset of companies as they continue to increase their role in drug development and innovation. The goal of our Phase II-III CRO Benchmarking—Small Pharma Market (5th Ed.) report is two-fold: - Help small and emerging biopharma companies make more informed CRO selection decisions - Help CROs optimize operational and marketing strategies to better accommodate small and emerging biopharma companies With this research, both sponsors and providers can glean what they need to make the best decisions possible for their clinical development programs and service offerings. Download a preview: https://lnkd.in/ec_M7JBU #clinicaltrials #drugdevelopment #pharma #marketresearch

Reminder to Register for Our Webinar! Origins - The Patient Focused Specialists are excited to remind you about our upcoming webinar on Monday, 17th June at 4pm BST. This is your chance to learn how patient experience data can drive impactful decisions in pharma. Register now: https://lnkd.in/e533vHJq We are pleased to present a panel of esteemed experts who will cover the following topics: • Hayley Chapman, Senior Program Director at The Synergist: The Patient Perspective • Anders B., Senior Director at Lundbeck: Use in Early Drug Development • Tom Willgoss, Patient-Centred Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche: Use in Clinical Trial Development If you have any questions you'd like addressed during the session, please email them to research@origins-patients.com once you've registered. This is a great opportunity to deepen your understanding of how patient data can enhance pharmaceutical practices. We look forward to your participation and insightful questions. #PatientFocused #PatientExperienceData #PatientData #Webinar #Pharma

Harnessing the power of digital innovation to deliver world-class life sciences projects. “The past few years have made clear more than ever before how critical the healthcare sector is and we understand the projects we’re delivering have the potential to be focal points for real change.” Mercury’s teams utilise expertise gained over 40 years in the life sciences sector as well as innovative onsite and offsite solutions to deliver large-scale, specialized projects for top corporations. In the article below, Robert O Donovan Business Unit Director for Life Sciences shares what sets Mercury apart and what it takes to deliver best in class pharmaceutical facilities across Europe. https://lnkd.in/gnND-c9Q

🌟 Accelerating Clinical Trials: A Glimpse into Good Governance 🌟 🔍 Enlightening Article Alert! We've found a valuable piece by Sierra Nesbit and Erik Moen from Life Science Leader that delves deep into the essence of effective clinical trial governance! 🚀 Agility in the Spotlight! The pandemic highlighted the need for rapid adaptability and innovations within the pharmaceutical industry, with companies like Pfizer and Moderna leading the way in accelerated vaccine development and launch. 📌 Revamping Governance Structures The article emphasises the urgent need to reform slow-moving governance structures to reduce time to market. It champions a flexible project management style, promoting adaptability and cross-functional collaboration to optimize economic performance and enhance patient access to care. 🌐 Mayet's Perspective At Mayet, we align with the principles of proficient vendor governance. We advocate for empowering representatives and avoiding the hierarchical restraints of traditional models, enabling quick and effective decision-making. Our commitment is to relentless innovation and excellence, striving to elevate governance standards in clinical trials where quality and compliance take centre stage. 🔗 Explore Dive into the transformative insights from this article and join the conversation on improving governance in clinical trial development: https://lnkd.in/e3pP9XiF #clinicaltrials #governance #innovation #MayetInsights

🚨 LAST CHANCE! ⏳ Act now before it's too late! The Clinical Data Disclosure Event is just a month away on March 19-20! Don't wait - FINAL SAVINGS end TONIGHT at midnight! Reserve your spot NOW to secure reduced-rate accommodation options! Don't miss out on this opportunity! ➡️ https://bit.ly/3I0Mojy 📱 Registered attendees gain EXCLUSIVE access to the event app! Stay connected, engaged, and informed. Plus, access valuable content from last year's EU event. 🤝 Network with industry GIANTS like Novartis, Regeneron, Biogen, and more! Rub shoulders with esteemed organizations such as Taylor & Francis Group, The National Institutes of Health, Otsuka Pharmaceutical Companies (U.S.), Sanofi, Merck Group, Amgen, and more! #CDDUS #ClinicalDataDisclosure #Healthcare #Networking #DataTransparency #ProtectingData #Redaction #DisclosureObligations #PlainLanguageSummaries #StrategyDisclosure

📣 Exciting News Announcement: Anju's TA Scan Selected by Leading Pharma Company to Enhance Clinical Research 🔥 Anju's clinical and commercial intelligence solution TA Scan revolutionizes clinical research for a top pharmaceutical company, enhancing data quality, enrollment benchmarking, and therapeutic area expansion. 🚀 This pharmaceutical leader invested more than 400 hours in performing an internal benchmarking study against their existing data provider, and the conclusion was clear: TA Scan data and analytics are much more powerful. 💪 Learn how this strategic partnership drives innovation and excellence in healthcare in our latest blog post: https://lnkd.in/e-3AC5q2 #LifeSciences #ClinicalResearch #ClinicalTrials #BigPharma #DataScience #businessintelligence #TrialFeasibility #KOLidentification #TAScan

🚨 LAST CHANCE! ⏳ Act now before it's too late! The Clinical Data Disclosure Event is just a month away on March 19-20! Don't wait - FINAL SAVINGS end TONIGHT at midnight! Reserve your spot NOW to secure reduced-rate accommodation options! Don't miss out on this opportunity! ➡️ https://bit.ly/3I0Mojy 📱 Registered attendees gain EXCLUSIVE access to the event app! Stay connected, engaged, and informed. Plus, access valuable content from last year's EU event. 🤝 Network with industry GIANTS like Novartis, Regeneron, Biogen, and more! Rub shoulders with esteemed organizations such as Taylor & Francis Group, The National Institutes of Health, Otsuka Pharmaceutical Companies (U.S.), Sanofi, Merck Group, Amgen, and more! #CDDUS #ClinicalDataDisclosure #Healthcare #Networking #DataTransparency #ProtectingData #Redaction #DisclosureObligations #PlainLanguageSummaries #StrategyDisclosure

With double of the US population and universal healthcare access, Europe represents the second largest healthcare market in the world.    Today we bid farewell to our “Think about Europe” series of posts; through which we described the challenges and commercial opportunity that Europe represents for US-based pharmaceutical and biotech companies looking to expand their footprint.    The topics we have discussed during the campaign are linked here and outlined below >> https://lnkd.in/dtbB3CAM   Our overall recommendations to manufacturers are: A) Think about Europe early in the clinical development process to maximise the European opportunity, we recommend it to be no later than in Phase II clinical trials.    B) Understand country level reimbursement processes and pricing potential to help decision-makers think more intelligently about resource allocation in the long term    c) Consider engaging with an experienced partner for European market access to mitigate the potential commercialisation challenges down the road.   The Cogentia team are well prepared to help you identify potential pitfalls for the European market and bring much needed treatments to patients across Europe.    #marketaccess #europe #HEOR  

Unlock the full potential of digital innovation in clinical operations with our latest report. The State of Digital Excellence in Clinical Operations includes findings from a comprehensive survey of senior clinical ops leaders across 18 large pharma companies and reveals critical insights into the pharmaceutical industry’s digital maturity. The report, authored by DT Research Director Francesca Properzi, also sheds light on the key gaps in organizational readiness and execution that are constraining the industry's progress towards digital excellence. The report’s actionable strategies are a balance of quick wins and long-term projects that can drive sustainable innovation in clinical operations. Don't miss your chance to stay ahead in today's dynamic landscape! https://lnkd.in/gxZuUTN7 #DigitalInnovation #ClinicalTrials #PharmaLeadership #InnovationStrategy

Synergy in Science - Partnering with Pharma As Day 9 of MedEvent-Mas unwraps, it reveals the essence of collaboration between medical event professionals and pharmaceutical companies. We work hand-in-glove with pharma companies to introduce breakthrough treatments and technologies that can transform lives to HCPs and patients/caregivers. Through educational workshops, we bridge the knowledge gap, enabling healthcare professionals to stay at the forefront of medical advancements and to deliver the best patient care. Discussions on drug development and usage are vital. They are not one-way streets but dynamic dialogues where feedback flows and informs the next wave of innovation. So many believe that meetings and events are about logistics alone. These events are about shared visions. Aligning closely with pharma companies, we ensure that every aspect of the event reflects the rigor and promise of the science presented. Together, we help shape the global healthcare narratives, making the latest pharmaceutical developments accessible and understandable. Let's keep the conversation going as we continue to explore the multifaceted roles in medical event planning. Here's to the partnerships that push the boundaries of healthcare! #medicalcommunications #medcomm #lifesciences #pharma #biotech #meetingsandevents #medicalmeetings #christmas #adventcalendar #medeventmas #medeventmasseries #mmp #partnerships